Anti-CD20 therapy reduces microglial activation and lesion volume in focal models of pattern I and pattern II multiple sclerosis

被引：0
|
作者：
Anthony, D. C.
Campbell, S. J.
Seneca, N.
Balazs, M.
Leppert, D.
机构：
[1] Univ Oxford, Oxford, England
[2] Roche, Basel, Switzerland
[3] Genentech Inc, San Francisco, CA 94080 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P734
引用
收藏
页码：S325 / S326
页数：2
相关论文
共 50 条
  • [21] Circulating and Cerebrospinal Fluid Monocytes in Relapsing-Remitting Multiple Sclerosis: Implications of Anti-CD20 Therapy
    Hansen, Marie Mathilde
    El Mahdaoui, Sahla
    Hansen, Malene Bredahl
    Hvalkof, Victoria
    Mahler, Mie Reith
    Soendergaard, Helle Bach
    Jennum, Poul Jorgen
    Sellebjerg, Finn
    von Essen, Marina Rode
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 238 - 238
  • [22] Effects of anti-CD20 therapy on circulating and intrathecal T follicular helper cell subsets in multiple sclerosis
    El Mahdaoui, Sahla
    Hansen, Marie Mathilde
    Hansen, Malene Bredahl
    Hvalkof, Victoria
    Soendergaard, Helle Bach
    Mahler, Mie Reith
    Christensen, Jeppe Romme
    Sellebjerg, Finn
    von Essen, Marina Rode
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 234 - 234
  • [23] Humoral response to COVID-19 variants in people with Multiple Sclerosis: Impact of Anti-CD20 Therapy
    Shawe-Taylor, Marianne
    Greenwood, David
    He, Anna
    Hobbs, Agnieszka
    Dowgier, Giulia
    Penn, Rebecca
    Sanderson, Theo
    Stevenson-Leggett, Phoebe
    Bazire, James
    Harvey, Ruth
    Champsas, Dimitrios
    Aojula, Anuriti
    Bianchi, Alessia
    Al-Araji, Sarmad
    Hacohen, Yael
    Kassiotis, George
    Gamblin, Steve
    Lewis, Nicola
    Williams, Bryan
    Swanton, Charles
    Gandhi, Sonia
    Bauer, David
    Wu, Mary
    Carr, Edward
    Wall, Emma
    Ciccarelli, Olga
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 505 - 506
  • [24] Anti-CD20 monoclonal antibody in multiple sclerosis therapy: the results of phase 3 clinical studies on relapsing and primary progressive multiple sclerosis
    Maciejowski, Maciej
    AKTUALNOSCI NEUROLOGICZNE, 2015, 15 (03): : 150 - 154
  • [25] CD11c+ B cells in relapsing-remitting multiple sclerosis and effects of anti-CD20 therapy
    El Mahdaoui, Sahla
    Hansen, Marie Mathilde
    von Essen, Marina Rode
    Hvalkof, Victoria Hyslop
    Hansen, Rikke Holm
    Mahler, Mie Reith
    Jennum, Poul
    Sellebjerg, Finn
    Christensen, Jeppe Romme
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (04): : 926 - 937
  • [26] Anti-CD20 therapy depletes activated myelin-specific CD8+ T cells in multiple sclerosis
    Sabatino, Joseph J., Jr.
    Wilson, Michael R.
    Calabresi, Peter A.
    Hauser, Stephen L.
    Schneck, Jonathan P.
    Zamvil, Scott S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (51) : 25800 - 25807
  • [27] Anti-CD20 Therapy Depletes Activated Myelin-Specific CD8+ T Cells in Multiple Sclerosis
    Sabatino, Joseph, Jr.
    Wilson, Michael
    Calabresi, Peter
    Hauser, Stephen
    Schneck, Jonathan
    Zamvil, Scott
    ANNALS OF NEUROLOGY, 2019, 86 : S271 - S271
  • [28] Functional characterization of reappearing B cells after anti-CD20 treatment in two animal models of multiple sclerosis
    Haeusler, D.
    Kinzel, S.
    Feldmann, L.
    Zamvil, S. S.
    Bernard, C. C. A.
    Brueck, W.
    Weber, M. S.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 464 - 465
  • [29] Immunological Response to COVID-19 Vaccine Boosters in Multiple Sclerosis Patients Treated with anti-CD20 Therapy
    De Oliveira, Antonia
    Lei, Joyce
    Liu, Jiayuan
    Roche, Morgan
    Lin, Jerry
    Alfonso, Roberto
    Sadiq, Saud
    NEUROLOGY, 2023, 100 (17)
  • [30] Influence of Body Mass Index on B Lymphocyte Repopulation in Multiple Sclerosis Patients Treated with Anti-CD20 Therapy
    Loeffler, Jacob
    Han, May
    NEUROLOGY, 2023, 100 (17)
12345